STOCK TITAN

Borealis Foods Warrant (BRLSW) Financials

BRLSW NASDAQ
Trailing 12 months to March 31, 2026
Revenue $30.6M +15.0% YoY
Net Income -$18.3M n/m YoY
EPS (Diluted) -$0.43 n/m YoY
Operating Cash Flow -$5.3M n/m YoY
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Jun 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BRLSW SEC filings page.

Borealis Foods Inc. Warrant (BRLSW) reported $30.6M in revenue over the twelve months to Mar 31, 2026, up 15.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BRLSW FY2025

FY2025 showed better unit economics, but liabilities outran assets, leaving operations dependent on financing while losses persisted.

Gross margin expansion from 7.9% in FY2024 to 11.7% in FY2025 coincided with revenue recovery, but the improvement was not enough to produce operating profit. That margin expansion also coincided with SG&A falling from $22.6M to $14.5M, indicating lower overhead helped alongside better product-level economics.

Balance-sheet pressure intensified: FY2025 liabilities of $71.8M exceeded assets of $52.6M, leaving equity negative at $19.2M. A 0.1x current ratio alongside current liabilities of $69.8M points to severe short-term funding tightness.

Operating cash flow was -$6.6M while the net loss was $19.0M, so cash consumption was smaller than the accounting loss but operations still did not fund themselves. Financing supplied $6.1M while operating cash flow remained negative, showing continued reliance on external funding.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 26 / 100
Financial Health Score (5 of 6 dimensions) 26/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Borealis Foods Inc. Warrant's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
1

Borealis Foods Inc. Warrant held $64K in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $6.6M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Borealis Foods Inc. Warrant scores 1/100 among other emerging companies.

Dilution
n/a

Not available for Borealis Foods Inc. Warrant, so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

R&D Intensity
6

Borealis Foods Inc. Warrant spent $202K on research and development in fiscal year 2025, which was 0.5% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Borealis Foods Inc. Warrant scores 6/100 among other emerging companies.

Revenue Progress
44

Borealis Foods Inc. Warrant reported revenue of $30.1M in fiscal year 2025, against $27.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Borealis Foods Inc. Warrant scores 44/100 among other emerging companies.

Burn Trend
80

Borealis Foods Inc. Warrant's operations used $6.6M of cash in fiscal year 2025, against $15.1M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Borealis Foods Inc. Warrant scores 80/100 among other emerging companies.

Balance Sheet
1

Borealis Foods Inc. Warrant's cash, cash equivalents and investments came to $64K at the end of fiscal year 2025, against $71.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Borealis Foods Inc. Warrant scores 1/100 among other emerging companies.

Piotroski F-Score Partial
4/7

Borealis Foods Inc. Warrant passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Borealis Foods Inc. Warrant reported a net loss of $19.0M while operations used $6.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Borealis Foods Inc. Warrant reported an operating loss of $11.0M against $6.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$7.4M
YoY+7.6%
QoQ-17.6%

Borealis Foods Inc. Warrant generated $7.4M in revenue in Q1 2026. This represents an increase of 7.6% from the same quarter a year earlier. Against the prior quarter it is down 17.6%.

EBITDA
-$1.7M
YoYn/m

Borealis Foods Inc. Warrant's EBITDA was -$1.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net Income
-$3.5M
YoYn/m
QoQn/m

Borealis Foods Inc. Warrant reported a net loss of $3.5M in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.16
YoYn/m
QoQn/m

Borealis Foods Inc. Warrant earned -$0.16 per diluted share (EPS) in Q1 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$500K
YoY+159.7%
QoQ+681.3%

Borealis Foods Inc. Warrant held $500K in cash as of Q1 2026; no long-term debt figure is on record for that period.

Shares Outstanding
21M
YoY+0.4%

Borealis Foods Inc. Warrant had 21M shares outstanding in Q1 2026. This represents an increase of 0.4% from the same quarter a year earlier.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin
11.4%
YoY-1.7pp
QoQ-0.4pp

Borealis Foods Inc. Warrant's gross margin was 11.4% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Operating Margin
-28.0%
YoY+14.6pp
QoQ+3.8pp

Borealis Foods Inc. Warrant's operating margin was -28.0% in Q1 2026, reflecting core business profitability. This is up 14.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.

Net Margin
-47.7%
YoY+13.5pp
QoQ+24.0pp

Borealis Foods Inc. Warrant's net profit margin was -47.7% in Q1 2026, showing the share of revenue converted to profit. This is up 13.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.0 percentage points.

Return on Equity

Not reported for Q1 2026.

Capital Allocation

R&D Spending
$50K
YoY-3.8%
QoQ+8.7%

Borealis Foods Inc. Warrant invested $50K in research and development in Q1 2026. This represents a decrease of 3.8% from the same quarter a year earlier. Against the prior quarter it is up 8.7%.

Share Buybacks

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

BRLSW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRLSW quarterly income statement
MetricQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/AQ3'2410-QQ2'2410-Q
Revenue$7.4M+7.6%$8.9M+32.3%$7.1M-7.6%$7.2M+35.0%$6.8M-13.3%$6.8M-9.4%$7.7M-0.5%$5.3M-17.4%
Cost of Revenue$6.5M+9.8%$7.9M+21.2%$6.1M-5.5%$6.7M+36.1%$5.9M-22.3%$6.5M-5.7%$6.4M-21.8%$4.9M-34.5%
Gross Profit$839K-6.8%$1.1M+320.2%$1.0M-18.3%$515K+21.9%$900K+270.9%$251K-54.8%$1.3Mn/m$422Kn/m
R&D Expenses$50K-3.8%$46K-14.8%$52K-7.1%$52K+4.0%$52K+40.5%$54K-75.8%$56K+51.4%$50Kn/m
SG&A Expenses$2.9M-24.0%$3.9M-20.1%$3.0M-39.4%$3.9M-31.0%$3.8M-47.1%$4.9M-3.9%$4.9M+24.0%$5.6M+3.7%
Operating Income-$2.1Mn/m-$2.8Mn/m-$1.9Mn/m-$3.4Mn/m-$2.9Mn/m-$4.6Mn/m-$3.6Mn/m-$5.2Mn/m
EBITDA-$1.7Mn/mN/A-$517Kn/mN/A-$2.4Mn/m-$5.5Mn/m-$1.8Mn/m-$4.8Mn/m
Interest Expense$1.5M+15.1%$1.6M+26.8%$1.9M+53.6%$1.2M+11.8%$1.3M-13.7%$1.3M-25.6%$1.2M-44.3%$1.1M-40.2%
Income TaxN/AN/AN/A$14K-0.9%N/A-$150Kn/m$832n/m$14K-7.2%
Net Income-$3.5Mn/m-$6.4Mn/m-$3.8Mn/m-$4.6Mn/m-$4.2Mn/m-$25.3Mn/m-$4.8Mn/m-$6.3Mn/m
EPS (Basic)-$0.16n/m-$0.30n/m-$0.18n/m$0.21-27.6%-$0.20n/m-$1.25-$0.23$0.29
EPS (Diluted)-$0.16n/m-$0.30n/m-$0.18n/m$0.21-27.6%-$0.20n/m-$1.25-$0.23$0.29
Diluted Shares (Avg)21M+0.2%N/A21M+0.4%21M+0.1%21M+25.2%20M21M21M

BRLSW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRLSW quarterly balance sheet
MetricQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/AQ3'2410-QQ2'2410-Q
Total Assets$50.9M-12.8%$52.6M-12.4%$56.3M-9.1%$57.3M-9.9%$58.4M-17.0%$60.0M-8.8%$61.9M+186.5%$63.6M+200.9%
Current Assets$6.8M-35.4%$8.1M-31.7%$9.5M-29.5%$9.9M-34.4%$10.6M-52.3%$11.8M-31.3%$13.4M+16094.4%$15.1M+610873.7%
Cash & Equivalents$500K+159.7%$64K-90.2%$129K-82.1%$207K-93.4%$193K-97.7%$653K-91.4%$722K-92.0%$3.1M-75.4%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Inventory$3.5M-54.4%$4.6M-43.0%$6.0M-31.5%$7.0M-8.6%$7.8M+13.9%$8.0M+15.9%$8.8M$7.7M
Accounts Receivable$1.7M-2.1%$2.6M+34.7%$2.6M-11.5%$2.3M-8.9%$1.8M-62.7%$2.0M+10.7%$2.9M$2.5M
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
GoodwillN/AN/A$1.9M0.0%$1.9M0.0%$1.9M0.0%$1.9M0.0%$1.9M$1.9M
Total Liabilities$73.6M+16.5%$71.8M+18.3%$69.2M+21.8%$66.4M+23.8%$63.2M+16.8%$60.7M-30.3%$56.8M+56.2%$53.7M+76.4%
Current Liabilities$71.8M+100.3%$69.8M+174.8%$64.1M+111.6%$39.4M+37.6%$35.9M+24.5%$25.4M-62.3%$30.3M+396.2%$28.7M+508.5%
Non-Current Liabilities$1.8M-93.4%$2.0M-94.4%$5.1M-80.7%$27.0M+7.9%$27.4M+8.0%$35.3M+78.0%$26.5M-12.4%$25.0M-2.7%
Long-Term DebtN/AN/A$3.0MN/AN/AN/AN/AN/A
Total Equity-$22.7Mn/m-$19.2Mn/m-$12.9M-355.4%-$9.2M-192.6%-$4.8M-129.8%-$696Kn/m$5.1Mn/m$9.9Mn/m
Retained Earnings-$113.3Mn/m-$109.8Mn/m-$103.4Mn/m-$99.6Mn/m-$95.0Mn/m-$90.8Mn/m-$85.0Mn/m-$80.2Mn/m

BRLSW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRLSW quarterly cash flow statement
MetricQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/AQ3'2410-QQ2'2410-Q
Operating Cash Flow-$123Kn/m-$2.8Mn/m-$191Kn/m-$2.2Mn/m-$1.4Mn/m-$819Kn/m-$3.3Mn/m-$4.2Mn/m
Depreciation & Amortization$386K-19.7%$433K-6.5%$1.4M-24.3%N/A$481K-51.6%$463K-53.6%$1.9M+86.7%$395K-58.9%
Stock-Based CompensationN/AN/A$0-100.0%$0n/m$58K-95.4%N/A$1.3M+1173.0%$0-100.0%
Capital ExpendituresN/AN/AN/AN/A$16K-97.1%$132K-86.1%$454K-31.4%$514K-73.4%
Free Cash FlowN/AN/AN/AN/A-$1.4Mn/m-$952Kn/m-$3.7Mn/m-$4.7Mn/m
Investing Cash FlowN/A-$4Kn/m-$33Kn/m-$3Kn/m-$26Kn/m-$198Kn/m-$497Kn/m-$724Kn/m
Financing Cash Flow$539K-42.5%$2.8M+192.6%$146K-89.3%$2.2Mn/m$938K-88.1%$949K-38.5%$1.4M-23.2%-$124K-101.7%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

BRLSW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRLSW quarterly financial ratios
MetricQ1'2610-QQ4'2510-K/AQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K/AQ3'2410-QQ2'2410-Q
Gross Margin11.4%-1.7pp11.8%+8.1pp14.6%-1.9pp7.2%-0.8pp13.1%+10.1pp3.7%-3.7pp16.6%+22.7pp7.9%+24.1pp
Operating Margin-28.0%+14.6pp-31.7%+36.6pp-27.1%+20.0pp-46.7%+50.8pp-42.6%+45.7pp-68.4%-7.8pp-47.1%+10.2pp-97.5%
Net Margin-47.7%+13.5pp-71.7%-53.2%+9.6pp-64.0%-61.2%-374.7%-62.8%+22.4pp-118.3%
Return on EquityN/AN/AN/AN/AN/AN/A-95.3%-63.6%
Return on Assets-6.9%+0.3pp-12.2%+30.0pp-6.7%+1.1pp-8.0%+1.9pp-7.2%+4.8pp-42.2%-0.4pp-7.8%+22.7pp-9.9%+29.4pp
Current Ratio0.10-0.2x0.12-0.3x0.15-0.3x0.25-0.3x0.29-0.5x0.46+0.2x0.44+0.4x0.53+0.5x
Liabilities-to-EquityN/AN/AN/AN/AN/AN/A11.215.42
Asset Turnover0.140.0x0.17+0.1x0.130.0x0.130.0x0.120.0x0.110.0x0.12-0.2x0.08-0.2x
FCF MarginN/AN/AN/AN/A-20.3%+72.4pp-14.1%+24.8pp-48.4%+22.9pp-89.2%

Not reported in any period shown, so not listed: Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Note: Shareholder equity is negative (-$19.2M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.12), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Borealis Foods Inc. Warrant BRLSW FY2025 $30.1M -$19.0M -63.1% N/A 26/100
Zevia PBC ZVIA FY2025 $161.3M -$9.9M -6.2% $98.2M 65/100
SharkNinja, Inc. SN FY2025 $6.4B $701.4M 11.0% $30.6B 74/100
Levi Strauss & Co. LEVI FY2025 $6.3B $578.1M 9.2% $8.9B 55/100
The Gap, Inc. GAP FY2025 $15.4B $816.0M 5.3% $7.9B 58/100
Casella Waste Systems Inc CWST FY2025 $1.8B $7.9M 0.4% $6.4B 46/100

Frequently Asked Questions

Borealis Foods Inc. Warrant (BRLSW) reported $30.1M in total revenue for fiscal year 2025. This represents a 8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Borealis Foods Inc. Warrant (BRLSW) revenue grew by 8.7% year-over-year, from $27.7M to $30.1M in fiscal year 2025.

No, Borealis Foods Inc. Warrant (BRLSW) reported a net loss of $18.3M over the trailing 12 months to March 31, 2026. In fiscal year 2025 it reported a net loss of $19.0M, with a net profit margin of -63.1%.

Borealis Foods Inc. Warrant (BRLSW) reported diluted earnings per share of -$0.89 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Borealis Foods Inc. Warrant (BRLSW) had EBITDA of -$9.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Borealis Foods Inc. Warrant (BRLSW) had a gross margin of 11.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Borealis Foods Inc. Warrant (BRLSW) had an operating margin of -36.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Borealis Foods Inc. Warrant (BRLSW) had a net profit margin of -63.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Borealis Foods Inc. Warrant (BRLSW) recorded an outflow of $6.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Borealis Foods Inc. Warrant (BRLSW) had $52.6M in total assets as of fiscal year 2025, including both current and long-term assets.

Borealis Foods Inc. Warrant (BRLSW) invested $202K in research and development during fiscal year 2025.

Borealis Foods Inc. Warrant (BRLSW) had a current ratio of 0.12 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Borealis Foods Inc. Warrant (BRLSW) had a return on assets of -36.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Borealis Foods Inc. Warrant (BRLSW) held $64K in cash, cash equivalents and investments, and reported an operating cash outflow of $6.6M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Borealis Foods Inc. Warrant (BRLSW) has negative shareholder equity of -$19.2M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Borealis Foods Inc. Warrant (BRLSW) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Borealis Foods Inc. Warrant (BRLSW) reported a net loss of $19.0M while operations used $6.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Borealis Foods Inc. Warrant (BRLSW) reported an operating loss of $11.0M against $6.0M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Borealis Foods Inc. Warrant (BRLSW) scores 26 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Borealis Foods Inc. Warrant it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top